Abram Scientific
Abram's provides rapid coagulation diagnostics for improved clinical outcomes in hemostasis disorders.
Founded
2013Abram's provides rapid coagulation diagnostics for improved clinical outcomes in hemostasis disorders.
Abram Scientific was founded with the mission to revolutionize the diagnosis and management of coagulation-related disorders through rapid and precise blood management solutions. Their core product, the CoagCare Platform, offers a portable, low-cost diagnostic solution that delivers full viscoelastic curves and parameter generation in under minutes using minimal blood samples. This platform aims to provide accurate and actionable hemostasis information to improve clinical outcomes, particularly in critical care settings.
Notable affiliated individuals and investors in Abram Scientific include experts in medical diagnostics and healthcare innovation, although specific names are not provided. The company has achieved significant milestones by developing a handheld, wireless meter that is vibration-insensitive and utilizes single-use diagnostic test strips. This innovation has the potential to significantly impact patient care by enabling rapid and precise blood coagulation diagnostics, thereby improving treatment decisions and outcomes in real-time.
Companies similar to Abram Scientific include Coagulo Medical Technologies, iFirst Medical Technologies, Perosphere Technologies and Coagulation Sciences.
Abram Scientific was founded in 2013.
Abram Scientific's headquarters is located in Menlo Park, CA, US.
Abram Scientific's most recent funding round was for $3.9M (USD) in April 2021.
As of Apr 6, 2021, Abram Scientific has disclosed funding of $4.3M (USD). Undisclosed round amounts are excluded.
Abram Scientific has 5 employees as of Feb 4, 2024.
Coagulation Sciences
